On Feb. 24, 2025, breast cancer is the most common cancer in women worldwide, but survival chances vary…
On Feb. 19, 2025, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Feb. 19, 2025, research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences has discovered…
On Feb. 17, 2025, researchers from Texas Children’s Hospital in Houston announced that the four year old girl…
On Feb. 17, 2025, Stanford researchers have conducted the first large-scale screen of these inherited changes, called single…
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
Jan. 24, 2025, the U.S. Food and Drug Administration (FDA) pulled draft guidance from its website requiring companies…
On Jan. 15, 2025, the U.S. Food and Drug Administration (FDA) announced revoking the authorization for the use…
On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…
On Jan. 13, 2025, scientists from the Francis Crick Institute, UCL, UCLH and Personalis announced they have found…
On Jan. 10, 2025, researchers at Roswell Park Comprehensive Cancer Center have identified a previously unknown cause of…
On Jan. 3, 2025, the U.S. Environmental Protection Agency announced the automatic addition of nine per- and polyfluoroalkyl…
On Jan. 3, 2025, the U.S. General Dr. Vivek Murthy released a new Surgeon General’s Advisory on Alcohol…
On Jan. 2, 2025, an international study led by researchers at Karolinska Institutet in Sweden shows that AI-based…
On Dec. 20, 2024, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved BRAFTOVI® (encorafenib)…
On Dec. 18, 2024, the Barbara Ann Karmanos Cancer Institute announced that the new TheraBionic P1 device, an…
On Dec. 12, 2024, a study co-lead by researchers from the University of British Columbia, Vancouver General Hospital…
On Dec. 11, 2024, Massachusetts General Hospital (MGH), founding member of the Mass General Brigham healthcare system, announced…
On Dec. 4, 2024, The U.S. Food and Drug Administration (FDA) announced approved of AstraZeneca’s blockbuster drug Imfinzi…
On Dec. 4, 2024, researchers at the Centre for Genomic Regulation (CRG) in Barcelona announced they had discovered…
On Nov. 21, 2024, a study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why…
On Nov. 20, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
On Nov. 12, 2024, researchers from the University of Basel and University Hospital Basel announced they had developed…
On Nov. 12, 2024, a research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that…
On Nov. 8, 2024, Anixa Biosciences announced updated positive data from the Phase 1 clinical trial of its…
On Nov. 6, 2024, a trio of new studies with funding from Cancer Grand Challenges revealed the unfair advantage…
On Nov. 5, 2024, a cross-sectional study of data for 36 cancer types from 185 countries and territories…
On Oct. 29, 2024, a study led by Andrei Gudkov, PhD, DSci, at Roswell Park Comprehensive Cancer Center support…
On Oct. 29, 2024, a study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center (UCLA…
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…